News

Latest News:

MC2 Therapeutics A/S appoints Samia Kappe as Executive Vice President Sales & Marketing Europe

POSTED: April 4, 2019

Copenhagen, April 4th, 2019 – MC2 Therapeutics A/S, a late clinical-stage company focused on topical therapies for chronic inflammatory conditions, today announced the appointment of Samia Kappe as Executive Vice ...

READ FULL ARTICLE >

MC2 Therapeutics A/S announces first patient dosed in EU Phase 3 trial in psoriasis vulgaris

POSTED: January 6, 2019

  • First patient dosed in Phase 3 trial assessing the safety and efficacy of MC2-01  Cream in EU
  •  Topline results are expected in Q3 2019

Copenhagen, January 6th, 2019 – MC2 Therapeutics A/S, ...

READ FULL ARTICLE >

Upcoming Events:

April 28th - May 2nd, 2019

MC2 Therapeutics A/S to present at ARVO

READ MORE >

May 20th - 21st, 2019

MC2 Therapeutics A/S to present at Bio€quity Europe

READ MORE >

© mc2 therapeutics 2016